sesamin has been researched along with Degenerative Disc Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, J; He, Z; Jia, H; Xue, J; Yang, X | 1 |
| Li, K; Lv, C | 1 |
| Li, K; Li, Y; Mao, L; Xu, B; Zhao, J | 1 |
3 other study(ies) available for sesamin and Degenerative Disc Disease
| Article | Year |
|---|---|
The mechanism by which Naru 3 pill protects against intervertebral disc cartilage endplate degeneration based on network pharmacology and experimental verification.
Topics: bcl-2-Associated X Protein; Cartilage; Caspase 3; Humans; Intervertebral Disc; Intervertebral Disc Degeneration; Molecular Docking Simulation; Network Pharmacology | 2023 |
Intradiscal injection of sesamin protects from lesion-induced degeneration.
Topics: Animals; Dioxoles; Disease Models, Animal; DNA; Extracellular Matrix; Gene Expression Regulation; Intervertebral Disc; Intervertebral Disc Degeneration; Lignans; Magnetic Resonance Imaging; Nucleus Pulposus; Proteoglycans; Rats, Sprague-Dawley; RNA, Messenger | 2020 |
Sesamin inhibits lipopolysaccharide-induced inflammation and extracellular matrix catabolism in rat intervertebral disc.
Topics: Animals; Cell Movement; Cell Survival; Cells, Cultured; Cyclooxygenase 2; Dinoprostone; Dioxoles; Enzyme Activation; Extracellular Matrix; Inflammation; Interleukin-1beta; Intervertebral Disc; Intervertebral Disc Degeneration; JNK Mitogen-Activated Protein Kinases; Lignans; Lipopolysaccharides; Macrophages; MAP Kinase Signaling System; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Nucleus Pulposus; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; RNA, Messenger; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2016 |